Answers are grounded in this paper and cite their sources.
Intravesical gentamicin is effective in reducing the frequency of recurrent UTIs, offering a localized treatment option with limited systemic absorption, thereby reducing typical aminoglycoside-associated nephrotoxicity and ototoxicity risks. However, careful patient selection and monitoring are essential to managing potential safety concerns.
No takes yet. Share an insight, caveat, or question.
Tripdatabase (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: